Biosimilars have gotten off to a slow start in the marketplace. What change will most dramatically affect the adoption rate?
PBM Formulary and coverage decisions: 83%
New Legislation: 17%
HHS/CMS Policy Changes: 0%
September 2026 Question of the Month Results
October 1, 2026